EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Retrospective analysis of the tolerability and effectiveness of rimegepant for the acute treatment of migraine in adolescents

Konstantinos Tourlas iD, Sruthi Ilangovan iD, Chelsea White, Samantha L Irwin iD, Sara Pavitt iD

Headache: The Journal of Head and Face Pain · 2026-04 · 66 (4) · 829-834

DOI: 10.1111/head.70033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Headache: The Journal of Head and Face Pain, online erschienen am 06.02.2026. Verfasst von Konstantinos Tourlas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Headache Center, Department of Pediatric Neurology, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Migraine Disorders, Calcitonin Gene-Related Peptide Receptor Antagonists, Pyridines, Piperidines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aims to evaluate the tolerability and effectiveness of the off‐label use of rimegepant as acute migraine treatment in adolescents.

Background

Calcitonin gene‐related peptide (CGRP) levels are elevated during migraine attacks. Gepants, oral CGRP receptor antagonists, have demonstrated effectiveness as acute and preventive migraine treatment in adults. They are generally well tolerated with limited side effects. Their use for migraine is approved by the United States Food and Drug Administration (FDA) in adults; however, data on their use in adolescents remain limited.

Methods

This is a retrospective chart review of pediatric patients

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersCalcitonin Gene-Related Peptide Receptor AntagonistsPyridinesPiperidinesHumansAdolescentFemaleRetrospective StudiesMaleTreatment Outcome

Stichwörter der Autor:innen

calcitonin gene‐related peptidemigrainepediatric

Substanzen

Calcitonin Gene-Related Peptide Receptor Antagonistsrimegepant sulfatePyridinesPiperidines

Autor:innen und Institutionen

  • Pediatric Headache Center, Department of Pediatric Neurology, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • UT Health Austin Pediatric Neurosciences at Dell Children's, Dell Children's Medical Center and UT Health Austin, Austin, Texas, USA.
  • Department of Neurology, Dell Medical School at The University of Texas at Austin, Austin, Texas, USA.
  • Department of Pediatrics, Dell Medical School at The University of Texas at Austin, Austin, Texas, USA.

ORCID-Profile: Konstantinos Tourlas, Sruthi Ilangovan, Samantha L Irwin, Sara Pavitt

Zitieren

APA

Tourlas, K., Ilangovan, S., White, C., Irwin, S. L., & Pavitt, S. (2026). Retrospective analysis of the tolerability and effectiveness of rimegepant for the acute treatment of migraine in adolescents. Headache: The Journal of Head and Face Pain, 66(4), 829-834. https://doi.org/10.1111/head.70033

Vancouver

Tourlas K, Ilangovan S, White C, Irwin SL, Pavitt S. Retrospective analysis of the tolerability and effectiveness of rimegepant for the acute treatment of migraine in adolescents. Headache: The Journal of Head and Face Pain. 2026;66(4):829-834. doi:10.1111/head.70033

BibTeX
@article{Tourlas2026,
  author = {Tourlas, Konstantinos and Ilangovan, Sruthi and White, Chelsea and Irwin, Samantha L and Pavitt, Sara},
  title = {Retrospective analysis of the tolerability and effectiveness of rimegepant for the acute treatment of migraine in adolescents},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2026},
  volume = {66},
  number = {4},
  pages = {829--834},
  doi = {10.1111/head.70033}
}
Kostenlos starten →